quinazolines has been researched along with sincalide in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caignard P, DH; de Tullio, P; Delarge, J; Dewalque, D; Diouf, O; Masereel, B; Neven, P; Pirotte, B; Podona, T; Renard, P | 1 |
| Chen, JY; Jiang, Z; Long, F; Ren, YG; Tang, JC; Zhao, J | 1 |
| Luo, HS; Ren, HX; Tang, QC; Xia, H; Yan, L | 1 |
3 other study(ies) available for quinazolines and sincalide
| Article | Year |
|---|---|
Pyridothiadiazinedioxides structurally related to quinazolinones cholecystokinin/gastrin receptor ligands: synthesis and biological evaluation.
Topics: Animals; Chemical Phenomena; Chemistry, Physical; Kinetics; Ligands; Male; Quinazolines; Rats; Rats, Wistar; Receptor, Cholecystokinin A; Receptor, Cholecystokinin B; Receptors, Cholecystokinin; Sincalide; Structure-Activity Relationship; Thiadiazines | 1998 |
Shikonin enhances sensitization of gefitinib against wild-type EGFR non-small cell lung cancer via inhibition PKM2/stat3/cyclinD1 signal pathway.
Topics: A549 Cells; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Carcinoma, Non-Small-Cell Lung; Carrier Proteins; Cell Line, Tumor; Cell Survival; Cyclin D1; Drug Synergism; ErbB Receptors; Gefitinib; Humans; Immunohistochemistry; Lung Neoplasms; Membrane Proteins; Mice; Mice, Nude; Naphthoquinones; Quinazolines; Signal Transduction; Sincalide; STAT3 Transcription Factor; Thyroid Hormone-Binding Proteins; Thyroid Hormones | 2018 |
Evodiamine inhibits gastrointestinal motility via CCK and CCK1 receptor in water-avoidence stress rat model.
Topics: Animals; Avoidance Learning; Biomarkers; Disease Models, Animal; Gastrointestinal Motility; Male; Quinazolines; Rats; Rats, Sprague-Dawley; Receptors, Cholecystokinin; Sincalide; Stress, Psychological | 2018 |